Viral dynamics in primary HIV-1 infection

被引:96
作者
Lindbäck, S
Karlsson, AC
Mittler, J
Blaxhult, A
Carlsson, M
Briheim, G
Sönnerborg, A
Gaines, H [1 ]
机构
[1] Swedish Inst Infect Dis Control, S-17182 Solna, Sweden
[2] Karolinska Hosp, Karolinska Inst, Dept Infect Dis, Solna, Sweden
[3] Huddinge Univ Hosp, Karolinska Inst, Dept Infect Dis, S-14186 Huddinge, Sweden
[4] Huddinge Univ Hosp, Karolinska Inst, Div Clin Virol, S-14186 Huddinge, Sweden
[5] Jonkoping Hosp, Dept Infect Dis, Jonkoping, Sweden
[6] Linkoping Univ Hosp, Dept Infect Dis, S-58185 Linkoping, Sweden
[7] Los Alamos Natl Lab, Theoret Biol & Biophys Grp T10, Los Alamos, NM USA
[8] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA
关键词
primary HIV-1 infection; HIV-RNA; treatment;
D O I
10.1097/00002030-200010200-00009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: To study the natural course of viremia during primary HIV infection (PHI). Method: Eight patients were followed from a median of 5 days from the onset of PHI illness. Plasma HIV-1 RNA levels were measured frequently and the results were fitted to mathematical models. HIV-1 RNA levels were also monitored in nine patients given two reverse transcriptase inhibitors and a protease inhibitor after a median of 7 days from the onset of Pi-II illness. Results: HIV-1 RNA appeared in the blood during the week preceding onset of PHI illness and increased rapidly during the first viremic phase, reaching a peak at a mean of 7 days after onset of illness. This was followed by a phase of rapidly decreasing levels of HIV-1 RNA to an average of 21 days after onset. Viral density continued to decline thereafter but at a 5- to 50-fold lower rate; a steady-state level was reached at a median of 2 months after onset of PHI. Peak viral density levels correlated significantly with levels measured between days 50 and 600. Initiation of antiretroviral treatment during PHI resulted in rapidly declining levels to below 50 copies/ml. Conclusions: This study demonstrates the kinetic phases of viremia during PHI and indicates two new contributions to the natural history of HIV-1 infection: PHI peak levels correlate with steady-state levels and HIV-1 RNA declines biphasically; an initial rapid decay is usually followed by a slow decay, which is similar to the initial changes seen with antiviral treatment. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:2283 / 2291
页数:9
相关论文
共 34 条
[1]   ISOLATION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) FROM PLASMA DURING PRIMARY HIV-INFECTION [J].
ALBERT, J ;
GAINES, H ;
SONNERBORG, A ;
NYSTROM, G ;
PEHRSON, PO ;
CHIODI, F ;
VONSYDOW, M ;
MOBERG, L ;
LIDMAN, K ;
CHRISTENSSON, B ;
ASJO, B ;
FENYO, EM .
JOURNAL OF MEDICAL VIROLOGY, 1987, 23 (01) :67-73
[2]   RAPID DEVELOPMENT OF ISOLATE-SPECIFIC NEUTRALIZING ANTIBODIES AFTER PRIMARY HIV-1 INFECTION AND CONSEQUENT EMERGENCE OF VIRUS VARIANTS WHICH RESIST NEUTRALIZATION BY AUTOLOGOUS SERA [J].
ALBERT, J ;
ABRAHAMSSON, B ;
NAGY, K ;
AURELIUS, E ;
GAINES, H ;
NYSTROM, G ;
FENYO, EM .
AIDS, 1990, 4 (02) :107-112
[3]   Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus [J].
Borrow, P ;
Lewicki, H ;
Wei, XP ;
Horwitz, MS ;
Peffer, N ;
Meyers, H ;
Nelson, JA ;
Gairin, JE ;
Hahn, BH ;
Oldstone, MBA ;
Shaw, GM .
NATURE MEDICINE, 1997, 3 (02) :205-211
[4]   VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
BORROW, P ;
LEWICKI, H ;
HAHN, BH ;
SHAW, GM ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6103-6110
[5]   Report of the NIH Panel to Define Principles of Therapy of HIV Infection [J].
Carpenter, C ;
Feinberg, M ;
Aubry, W ;
Averitt, D ;
Coffin, J ;
Cooper, D ;
Follansbee, S ;
Hamburg, P ;
Harrington, M ;
Hidalgo, J ;
Jaffe, H ;
Landers, D ;
Masur, H ;
Pizzo, P ;
Richman, D ;
Saag, M ;
Schooley, R ;
Stone, V ;
Thompson, M ;
Trono, D ;
Vella, S ;
Walker, B ;
Yeni, P .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (12) :1057-1078
[6]   Early establishment of a pool of latently infected, resting CD4+ T cells during primary HIV-1 infection [J].
Chun, TW ;
Engel, D ;
Berrey, MM ;
Shea, T ;
Corey, L ;
Fauci, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) :8869-8873
[7]   HIGH TITERS OF CYTOPATHIC VIRUS IN PLASMA OF PATIENTS WITH SYMPTOMATIC PRIMARY HIV-1 INFECTION [J].
CLARK, SJ ;
SAAG, MS ;
DECKER, WD ;
CAMPBELLHILL, S ;
ROBERSON, JL ;
VELDKAMP, PJ ;
KAPPES, JC ;
HAHN, BH ;
SHAW, GM .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :954-960
[8]   CHARACTERIZATION OF LYMPHOCYTE-T RESPONSES DURING PRIMARY INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS [J].
COOPER, DA ;
TINDALL, B ;
WILSON, EJ ;
IMRIE, AA ;
PENNY, R .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (05) :889-896
[9]   TRANSIENT HIGH-LEVELS OF VIREMIA IN PATIENTS WITH PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
DAAR, ES ;
MOUDGIL, T ;
MEYER, RD ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :961-964
[10]   CLINICAL PICTURE OF PRIMARY HIV INFECTION PRESENTING AS A GLANDULAR-FEVER-LIKE ILLNESS [J].
GAINES, H ;
VONSYDOW, M ;
PEHRSON, PO ;
LUNDBERGH, P .
BRITISH MEDICAL JOURNAL, 1988, 297 (6660) :1363-1368